Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors

被引:26
|
作者
Yoshizawa, Kunio [1 ]
Nozaki, Shinichi [2 ]
Kitahara, Hiroko [1 ]
Kato, Koroku [1 ]
Noguchi, Natsuyo [1 ]
Kawashiri, Shuichi [1 ]
Yamamoto, Etsuhide [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Med Ctr, Natl Hosp Org, Kanazawa, Ishikawa, Japan
关键词
oral squamous cell carcinoma; urokinase-type plasminogen activator; urokinase-type plasminogen activator receptor; maspin; invasion; LYMPH-NODE METASTASIS; BREAST-CANCER; CAVITY; LOCALIZATION; INHIBITION; SYSTEM; UPAR;
D O I
10.3892/or.2011.1419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well documented that the binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR), which has been implicated in cancer invasion and metastasis, is regulated by several inhibitors such as maspin. In this study, we investigated the interrelationship between clinicopathologic findings and expression of uPA, uPAR and maspin in oral squamous cell carcinoma (OSCC) to elucidate the participation of maspin in the uPA/uPAR system in the malignant behavior of OSCC. Using immunohistochemical techniques to examine the expression levels of uPA, uPAR and maspin in 54 cases of OSCC, we also compared the clinicopathologic features of OSCC with the expression levels of each. Moreover, we examined the expression of uPA, uPAR and maspin in six cell lines derived from OSCC using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. uPA and uPAR showed a positive correlation with the mode of cancer invasion; conversely maspin showed a negative correlation with the mode of invasion. Multivariate analysis revealed that only two factors (N-category and uPA(+)/uPAR(+)/imaspin(-) expression pattern) were significant and independent variables with relative risks of 3.84 and 2.52, respectively. In particular, tumors exhibiting an expression pattern of uPA(+)/uPAR(+)/maspin(-) were highly malignant and were associated with the worst survival rate (5-year overall survival rate, 29.4%), while tumors with an expression pattern, uPA(-)/uPAR(-)/Maspin(+), showed the most favorable survival rate (5-year overall survival rate, 77.8%). In vitro, lower expression of maspin was also noted in the cell lines derived from grade 4D OSCC, which exhibited a stronger invasive potential than the cells lines derived from the other grades of OSCC, while uPA and uPAR demonstrated an expression trend opposite to maspin. These results indicate that uPA, uPAR and maspin expression patterns may be useful markers for evaluating the clinical course or prognosis of OSCC patients.
引用
收藏
页码:1555 / 1560
页数:6
相关论文
共 50 条
  • [1] Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system
    Yin, SP
    Lockett, J
    Meng, YH
    Biliran, H
    Blouse, GE
    Li, XH
    Reddy, N
    Zhao, ZM
    Lin, XL
    Anagli, J
    Cher, ML
    Sheng, SJ
    CANCER RESEARCH, 2006, 66 (08) : 4173 - 4181
  • [2] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [3] Expression of urokinase-type plasminogen activator and its receptor in squamous cell carcinoma of the oral tongue
    Serpa, Marianna Sampaio
    Mafra, Rodrigo Porpino
    Monteiro Lourenco Queiroz, Salomao Israel
    da Silva, Leorik Pereira
    de Souza, Lelia Batista
    Pinto, Leao Pereira
    BRAZILIAN ORAL RESEARCH, 2018, 32
  • [4] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [5] Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma
    Morita, Y
    Hayashi, Y
    Wang, Y
    Kanamaru, T
    Suzuki, S
    Kawasaki, K
    Ohta, K
    Yamamoto, M
    Saitoh, Y
    Itoh, H
    Doe, WF
    HEPATOLOGY, 1997, 25 (04) : 856 - 861
  • [6] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [7] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: Correlation with tumor associated macrophage and prognosis
    Ohba, K
    Miyata, Y
    Kanda, S
    Koga, S
    Hayashi, T
    Kanetake, H
    JOURNAL OF UROLOGY, 2005, 174 (02): : 461 - 465
  • [8] Expression of Urokinase-type Plasminogen Activator (uPA), uPA Receptor, and Plasminogen Activator Inhibitor-1 in Oral Squamous Cell Carcinoma
    Inoue, Yoshiko
    Sugiura, Tsuyoshi
    VIatsuki, Ryousuke
    Ishii, Kotaro
    Seki, Katsuhiro
    Shirasuna, Kanemitsu
    ORAL SCIENCE INTERNATIONAL, 2007, 4 (01) : 38 - 44
  • [9] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [10] Urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in small cell carcinoma of the lung and non-small cell carcinoma of the lung
    Wajima, T
    VonHoff, DD
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2264 - P2264